Literature DB >> 12019556

A practical approach for the diagnosis and management of dilated cardiomyopathy.

R Krishna Kumar1.   

Abstract

Dilated cardiomyopathy (DCM) refers to a group of conditions of diverse etiology in which both ventricles are enlarged with reduced contractility. Certain correctable conditions associated with ventricular dysfunction can masquerade as DCM. Most of them can be identified with relatively inexpensive and readily available tests. A typical diagnostic work-up for a child with DCM also includes a number of investigations to identify the underlying cause, some of which are expensive and sophisticated. The average center in the developing world often does not have the facilities to carry out these investigations. The results of many of these investigations typically do not translate into a specific management strategy that makes a difference to prognosis. A significant number of children with DCM will eventually develop end-stage heart failure that requires cardiac transplantation with or without bridging procedures. This is an unrealistic option for the developing world. The management strategy of childhood DCM in the developing world needs to be tailored to the resources available with in a manner such that the overall prognosis is not substantially affected.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019556     DOI: 10.1007/bf02723221

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  43 in total

1.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.

Authors:  V V Michels; P P Moll; F A Miller; A J Tajik; J S Chu; D J Driscoll; J C Burnett; R J Rodeheffer; J H Chesebro; H D Tazelaar
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

2.  The Registry of the International Society for Heart and Lung Transplantation: eleventh official report--1994.

Authors:  J D Hosenpud; R J Novick; T J Breen; O P Daily
Journal:  J Heart Lung Transplant       Date:  1994 Jul-Aug       Impact factor: 10.247

3.  Cardiac troponin T in patients with clinically suspected myocarditis.

Authors:  B Lauer; C Niederau; U Kühl; M Schannwell; M Pauschinger; B E Strauer; H P Schultheiss
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

Review 4.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060.

Authors:  P G Barth; R J Wanders; P Vreken
Journal:  J Pediatr       Date:  1999-09       Impact factor: 4.406

5.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

6.  Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation.

Authors:  A Matitiau; A Perez-Atayde; S P Sanders; T Sluysmans; I A Parness; P J Spevak; S D Colan
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

7.  Acute myocarditis. Rapid diagnosis by PCR in children.

Authors:  A B Martin; S Webber; F J Fricker; R Jaffe; G Demmler; D Kearney; Y H Zhang; J Bodurtha; B Gelb; J Ni
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

8.  Gamma-globulin treatment of acute myocarditis in the pediatric population.

Authors:  N A Drucker; S D Colan; A B Lewis; A S Beiser; D L Wessel; M Takahashi; A L Baker; A R Perez-Atayde; J W Newburger
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

9.  Role of right ventricular endomyocardial biopsy in infants and children with suspected or possible myocarditis.

Authors:  S A Webber; G J Boyle; R Jaffe; R M Pickering; L B Beerman; F J Fricker
Journal:  Br Heart J       Date:  1994-10

Review 10.  Carnitine metabolism and deficiency syndromes.

Authors:  C J Rebouche; A G Engel
Journal:  Mayo Clin Proc       Date:  1983-08       Impact factor: 7.616

View more
  2 in total

1.  Dilated Cardiomyopathy as the Only Clinical Manifestation of Carnitine Transporter Deficiency.

Authors:  Kyriaki Papadopoulou-Legbelou; Maria Gogou; Vaia Dokousli; Maria Eboriadou; Athanasios Evangeliou
Journal:  Indian J Pediatr       Date:  2016-11-03       Impact factor: 1.967

2.  Audit of therapeutic interventions in inpatient children using two scores: are they evidence-based in developing countries?

Authors:  Nilton Y Carreazo; Carlos A Bada; Juan P Chalco; Luis Huicho
Journal:  BMC Health Serv Res       Date:  2004-12-29       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.